PDIA3 and cervical cancer: Interestingly, ERp57 is downregulated in early-stage cervical cancer, whereas it is highly expressed in invasion-stage cervical cancer, suggesting that the role of the ERp57 in cancer is complex and closely related to its molecular partner [9, 15].